Compounds > fingolimod hydrochloride
Page last updated: 2024-09-02

fingolimod hydrochloride and axitinib

fingolimod hydrochloride has been researched along with axitinib in 1 studies

Compound Research Comparison

Studies
(fingolimod hydrochloride)		Trials
(fingolimod hydrochloride)		Recent Studies (post-2010)
(fingolimod hydrochloride)		Studies
(axitinib)		Trials
(axitinib)		Recent Studies (post-2010) (axitinib)
2,7711572,062765145683

Protein Interaction Comparison

ProteinTaxonomyfingolimod hydrochloride (IC50)axitinib (IC50)
Serine/threonine-protein kinase PLK4Homo sapiens (human)0.045
Tyrosine-protein kinase ABL1Homo sapiens (human)0.0658
Cytochrome P450 3A4Homo sapiens (human)0.046
Vascular endothelial growth factor receptor 1 Homo sapiens (human)0.0001
Vascular endothelial growth factor receptor 3Homo sapiens (human)0.0001
Vascular endothelial growth factor receptor 2Homo sapiens (human)0.0079
Serine/threonine-protein kinase TBK1Homo sapiens (human)0.47

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dintsios, CM; Rasch, A1

Reviews

1 review(s) available for fingolimod hydrochloride and axitinib

ArticleYear
[Subgroups in the early benefit assessment of pharmaceuticals: a methodical review].
    Zeitschrift fur Evidenz, Fortbildung und Qualitat im Gesundheitswesen, 2015, Volume: 109, Issue:1

    Topics: Adenosine; Anilides; Axitinib; Drug Approval; Effect Modifier, Epidemiologic; Fingolimod Hydrochloride; Germany; Humans; Imidazoles; Indazoles; National Health Programs; Pyridines; Risk Assessment; Sitagliptin Phosphate; Sofosbuvir; Ticagrelor

2015